166 related articles for article (PubMed ID: 29208003)
21. MicroRNA-3127 promotes cell proliferation and tumorigenicity in hepatocellular carcinoma by disrupting of PI3K/AKT negative regulation.
Jiang J; Zhang Y; Guo Y; Yu C; Chen M; Li Z; Tian S; Sun C
Oncotarget; 2015 Mar; 6(8):6359-72. PubMed ID: 25849943
[TBL] [Abstract][Full Text] [Related]
22. Targeting EMP3 suppresses proliferation and invasion of hepatocellular carcinoma cells through inactivation of PI3K/Akt pathway.
Hsieh YH; Hsieh SC; Lee CH; Yang SF; Cheng CW; Tang MJ; Lin CL; Lin CL; Chou RH
Oncotarget; 2015 Oct; 6(33):34859-74. PubMed ID: 26472188
[TBL] [Abstract][Full Text] [Related]
23. Trans-acting non-synonymous variant of FOXA1 predisposes to hepatocellular carcinoma through modulating FOXA1-ERα transcriptional program and may have undergone natural selection.
Wang S; Xiang C; Mou L; Yang Y; Zhong R; Wang L; Sun C; Qin Z; Yang J; Qian J; Zhao Y; Wang Y; Pan X; Qie J; Jiang Y; Wang X; Yang Y; Zhou WP; Miao X; He F; Jin L; Wang H
Carcinogenesis; 2020 Apr; 41(2):146-158. PubMed ID: 31400761
[TBL] [Abstract][Full Text] [Related]
24. Involvement of PI3K/Akt pathway in the inhibition of hepatocarcinoma cell invasion and metastasis induced by SASH1 through downregulating Shh-Gli1 signaling.
Sun C; Zhang Z; He P; Zhou Y; Xie X
Int J Biochem Cell Biol; 2017 Aug; 89():95-100. PubMed ID: 28600143
[TBL] [Abstract][Full Text] [Related]
25. Aquaporin 9 is down-regulated in hepatocellular carcinoma and its over-expression suppresses hepatoma cell invasion through inhibiting epithelial-to-mesenchymal transition.
Zhang WG; Li CF; Liu M; Chen XF; Shuai K; Kong X; Lv L; Mei ZC
Cancer Lett; 2016 Aug; 378(2):111-9. PubMed ID: 27216981
[TBL] [Abstract][Full Text] [Related]
26. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
Zheng Y; Jiang L; Hu Y; Xiao C; Xu N; Zhou J; Zhou X
BMC Cancer; 2017 Feb; 17(1):161. PubMed ID: 28241806
[TBL] [Abstract][Full Text] [Related]
27. Resveratrol inhibits proliferation and migration through SIRT1 mediated post‑translational modification of PI3K/AKT signaling in hepatocellular carcinoma cells.
Chai R; Fu H; Zheng Z; Liu T; Ji S; Li G
Mol Med Rep; 2017 Dec; 16(6):8037-8044. PubMed ID: 28983625
[TBL] [Abstract][Full Text] [Related]
28. STYK1 promotes epithelial-mesenchymal transition and tumor metastasis in human hepatocellular carcinoma through MEK/ERK and PI3K/AKT signaling.
Wang Z; Qu L; Deng B; Sun X; Wu S; Liao J; Fan J; Peng Z
Sci Rep; 2016 Sep; 6():33205. PubMed ID: 27628214
[TBL] [Abstract][Full Text] [Related]
29. The phosphoinositide 3-kinase regulatory subunit p85alpha can exert tumor suppressor properties through negative regulation of growth factor signaling.
Taniguchi CM; Winnay J; Kondo T; Bronson RT; Guimaraes AR; Alemán JO; Luo J; Stephanopoulos G; Weissleder R; Cantley LC; Kahn CR
Cancer Res; 2010 Jul; 70(13):5305-15. PubMed ID: 20530665
[TBL] [Abstract][Full Text] [Related]
30. Direct association of heat shock protein 20 (HSPB6) with phosphoinositide 3-kinase (PI3K) in human hepatocellular carcinoma: regulation of the PI3K activity.
Matsushima-Nishiwaki R; Kumada T; Nagasawa T; Suzuki M; Yasuda E; Okuda S; Maeda A; Kaneoka Y; Toyoda H; Kozawa O
PLoS One; 2013; 8(11):e78440. PubMed ID: 24223153
[TBL] [Abstract][Full Text] [Related]
31. FOXK2, regulted by miR-1271-5p, promotes cell growth and indicates unfavorable prognosis in hepatocellular carcinoma.
Lin MF; Yang YF; Peng ZP; Zhang MF; Liang JY; Chen W; Liu XH; Zheng YL
Int J Biochem Cell Biol; 2017 Jul; 88():155-161. PubMed ID: 28506857
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of brachyury contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma.
Du R; Wu S; Lv X; Fang H; Wu S; Kang J
J Exp Clin Cancer Res; 2014 Dec; 33(1):105. PubMed ID: 25499255
[TBL] [Abstract][Full Text] [Related]
33. MUC15 inhibits dimerization of EGFR and PI3K-AKT signaling and is associated with aggressive hepatocellular carcinomas in patients.
Wang RY; Chen L; Chen HY; Hu L; Li L; Sun HY; Jiang F; Zhao J; Liu GM; Tang J; Chen CY; Yang YC; Chang YX; Liu H; Zhang J; Yang Y; Huang G; Shen F; Wu MC; Zhou WP; Wang HY
Gastroenterology; 2013 Dec; 145(6):1436-48.e1-12. PubMed ID: 23933603
[TBL] [Abstract][Full Text] [Related]
34. FAM9C plays an anti-apoptotic role through activation of the PI3K/Akt pathway in human hepatocellular carcinoma.
Zhou JD; Shen F; Ji JS; Zheng K; Huang M; Wu JC
Oncol Rep; 2013 Sep; 30(3):1275-84. PubMed ID: 23836295
[TBL] [Abstract][Full Text] [Related]
35. Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway.
Zhang DM; Liu JS; Deng LJ; Chen MF; Yiu A; Cao HH; Tian HY; Fung KP; Kurihara H; Pan JX; Ye WC
Carcinogenesis; 2013 Jun; 34(6):1331-42. PubMed ID: 23393227
[TBL] [Abstract][Full Text] [Related]
36. Reciprocal activation between MMP-8 and TGF-β1 stimulates EMT and malignant progression of hepatocellular carcinoma.
Qin G; Luo M; Chen J; Dang Y; Chen G; Li L; Zeng J; Lu Y; Yang J
Cancer Lett; 2016 Apr; 374(1):85-95. PubMed ID: 26872724
[TBL] [Abstract][Full Text] [Related]
37. Long Noncoding RNA lncARSR Promotes Doxorubicin Resistance in Hepatocellular Carcinoma via Modulating PTEN-PI3K/Akt Pathway.
Li Y; Ye Y; Feng B; Qi Y
J Cell Biochem; 2017 Dec; 118(12):4498-4507. PubMed ID: 28464252
[TBL] [Abstract][Full Text] [Related]
38. The tumor-suppressor gene LZTS1 suppresses hepatocellular carcinoma proliferation by impairing PI3K/Akt pathway.
He Y; Liu X
Biomed Pharmacother; 2015 Dec; 76():141-6. PubMed ID: 26653561
[TBL] [Abstract][Full Text] [Related]
39. [Roles of PIK3R1 gene in development of hepatocellular carcinoma].
Zheng YX; Zhang CW; Hui B; Ding BY; Ao L; Dong B; Zhou XM
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2014 Sep; 43(5):559-65. PubMed ID: 25372641
[TBL] [Abstract][Full Text] [Related]
40. Hydrogen sulfide promotes autophagy of hepatocellular carcinoma cells through the PI3K/Akt/mTOR signaling pathway.
Wang SS; Chen YH; Chen N; Wang LJ; Chen DX; Weng HL; Dooley S; Ding HG
Cell Death Dis; 2017 Mar; 8(3):e2688. PubMed ID: 28333142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
